DUBLIN--(BUSINESS WIRE)--Mallinckrodt plc (NYSE: MNK), a global specialty pharmaceutical and global medical imaging company, will present at the Barclays Global Healthcare Conference in Miami, Florida on March 13, 2014. Mark Trudeau, President and CEO of Mallinckrodt will represent the company in a session scheduled to begin at 10:45AM EST.
A live audio webcast of the presentation can be accessed at Mallinckrodt’s Investor Relations website: http://www.mallinckrodt.com/investor_relations
ABOUT MALLINCKRODT:
Mallinckrodt is a global specialty pharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s Specialty Pharmaceuticals segment includes branded and specialty generic drugs and active pharmaceutical ingredients, and the Global Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt has approximately 5,500 employees worldwide and a commercial presence in roughly 70 countries. The company’s fiscal 2013 revenue totaled $2.2 billion. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
